Ocean Bio-Chem, Inc.

NasdaqCM:OBCI Stock Report

Market Cap: US$123.9m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Ocean Bio-Chem Future Growth

Future criteria checks 0/6

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Household Products earnings growth7.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt Responsibly

Jun 23
Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt Responsibly

Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising Future

Apr 07
Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising Future

Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding Machine

Dec 16
Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding Machine

Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03

Nov 26
Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03

Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft Earnings

Nov 22
Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft Earnings

These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt Safely

Nov 03
These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt Safely

Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03

Sep 02
Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03

With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is Interesting

Aug 17
With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is Interesting

Ocean Bio-Chem And Its Real Value

Aug 05

Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?

Jul 27
Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?

Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

May 29
Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On Capital

May 17
Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On Capital

Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather Sparingly

Mar 17
Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather Sparingly

Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-Dividend

Mar 05
Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-Dividend

Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend Rockstar

Feb 22
Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend Rockstar

Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)

Feb 09
Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)

Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Jan 27
Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?

Jan 14
Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?

This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

Jan 01
This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total Return

Dec 28
Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total Return

Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling

Dec 15
Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling

Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?

Dec 03
Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?

Ocean Bio-Chem goes ex-dividend tomorrow

Dec 01

Ocean Bio-Chem authorizes $3M share repurchase program

Nov 23

A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary

Nov 21
A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary

Ocean Bio-Chem Has Maintained Momentum, But Not Enough For New Highs

Nov 19

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ocean Bio-Chem has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqCM:OBCI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2022635-70N/A
3/31/2022648-44N/A
12/31/2021648-26N/A
9/30/202163905N/A
6/30/2021611047N/A
3/31/2021611157N/A
12/31/2020561046N/A
9/30/202052946N/A
6/30/202046645N/A
3/31/202041367N/A
12/31/201942356N/A
9/30/201941334N/A
6/30/201942312N/A
3/31/2019423-10N/A
12/31/2018423-11N/A
9/30/2018423-12N/A
6/30/2018403-22N/A
3/31/2018383-23N/A
12/31/2017383-23N/A
9/30/2017383-13N/A
6/30/201739303N/A
3/31/201738323N/A
12/31/201636233N/A
9/30/201636212N/A
6/30/201635000N/A
3/31/2016350N/A2N/A
12/31/2015340N/A1N/A
9/30/2015341N/A1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if OBCI's forecast earnings growth is above the savings rate (1.9%).

Earnings vs Market: Insufficient data to determine if OBCI's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if OBCI's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if OBCI's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if OBCI's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OBCI's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.